• Publications
  • Influence
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction that occurs following exposure to unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH). HIT withExpand
  • 44
  • 6
  • Open Access
Multi-screen electronic alerts to augment venous thromboembolism prophylaxis.
Venous thromboembolism (VTE) prophylaxis in high-risk patients is frequently underutilised. We previously devised a one-screen computer alert program that identified hospitalised patients at highExpand
  • 38
  • 2
Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry
Although there is emerging evidence that bleeding is a strong predictor of mortality in patients with acute arterial thrombosis receiving antithrombotic therapy [1–3], whether a similar associationExpand
  • 29
  • 1
Fondaparinux in the initial and long-term treatment of venous thromboembolism.
BACKGROUND Even in the absence of evidence on its long-term efficacy and safety, a number of patients with venous thromboembolism (VTE) receive long-term therapy with fondaparinux alone in everydayExpand
  • 13
  • 1
Incidence of arterial embolism in patients on treatment with old and new anticoagulants for venous thromboembolism.
The separate nature of venous and arterial thrombotic disorders has recently been challenged. Patients with venous thromboembolism (VTE) have an increased risk of subsequent symptomatic arterialExpand
  • 2
Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Once anticoagulation is stopped, the risk of recurrent venous thromboembolism (VTE) over years after a first episode is consistently around 30%. This risk is higher in patients with unprovoked thanExpand
  • 20
  • Open Access
The value of 64-detector row computed tomography for the exclusion of pulmonary embolism.
Recently, a diagnostic strategy using a clinical decision rule, D-dimer testing and spiral computed tomography (CT) was found to be effective in the evaluation of patients with clinically suspectedExpand
  • 20
  • Open Access
Venous thromboembolism and arterial complications.
An increasing body of evidence suggests the likelihood of a link between venous and arterial thrombosis. The two vascular complications share several risk factors, such as age, obesity, smoking,Expand
  • 14
Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry
Stratification of the individual bleeding risk prior to initiation of anticoagulation in patients with acute venous thromboembolism (VTE) has the potential to assist clinicians in making decisionsExpand
  • 19
What are the pharmacotherapy options for treating venous thromboembolism in cancer patients?
Introduction: Venous thromboembolism (VTE) is a frequent complication in patients with malignancies. The treatment of VTE disorders in cancer patients remains a difficult clinical task. AreasExpand
  • 4